Active Ingredient: Zanamivir
Zanamivir is indicated for treatment of both influenza A and B in adults and children (≥5 years) who present with symptoms typical of influenza when influenza is circulating in the community.
For this indication, competent medicine agencies globally authorize below treatments:
Respiratory (Inhalation)
20 - 20 mg
From 10 To 10 mg 2 time(s) per day every day
Treatment should begin as soon as possible, within 48 hours after onset of symptoms for adults, and within 36 hours after onset of symptoms for children.
Zanamivir is for administration to the respiratory tract by oral inhalation only.
The recommended dose of zanamivir for treatment of influenza in adults and children from the age of 5 years is two inhalations (2 × 5 mg) twice daily for five days, providing a total daily inhaled dose of 20 mg.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
